MedPath
NMPA Approval

Lenvatinib Mesilate Capsules

国药准字H20249044

October 9, 2024

Drug Information

甲磺酸仑伐替尼胶囊

胶囊剂

4mg(按C₂₁H₁₉ClN₄O₄ 计)

化学药品

October 9, 2024

Company Information

Applicant Company

重庆市渝北区人和镇星光大道100号

Manufacturing Company

重庆市渝北区人和镇星光大道100号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.